Cargando…

Assessment of In vivo Antiviral Potential of Datura metel Linn. Extracts against Rabies Virus

OBJECTIVE: The soxhlet, cold, and ayurvedic extracts of Datura metel Linn. were evaluated for in vivo antirabies activity. MATERIALS AND METHODS: Soxhlet and cold extraction method were used to extract Datura (fruit and seed) extracts, and ayurvedic extraction of Datura was prepared. In vivo toxicit...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Soumen, Samant, Lalit, Ganjhu, Rajeshkumar, Mukherjee, Sandeepan, Chowdhary, Abhay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855366/
https://www.ncbi.nlm.nih.gov/pubmed/29568197
http://dx.doi.org/10.4103/pr.pr_121_17
_version_ 1783307086660108288
author Roy, Soumen
Samant, Lalit
Ganjhu, Rajeshkumar
Mukherjee, Sandeepan
Chowdhary, Abhay
author_facet Roy, Soumen
Samant, Lalit
Ganjhu, Rajeshkumar
Mukherjee, Sandeepan
Chowdhary, Abhay
author_sort Roy, Soumen
collection PubMed
description OBJECTIVE: The soxhlet, cold, and ayurvedic extracts of Datura metel Linn. were evaluated for in vivo antirabies activity. MATERIALS AND METHODS: Soxhlet and cold extraction method were used to extract Datura (fruit and seed) extracts, and ayurvedic extraction of Datura was prepared. In vivo toxicity assay was performed as per the OECD 420. LD(50) dose was calculated by Reed and Muench method. The in vivo antirabies activity was screened in Swiss albino mice with the virus challenge dose of 10 LD(50) (intracerebrally) in both preexposure (PE) and postexposure treatment with oral administration of Datura extracts in Swiss albino mice and observed for 21 days. The virus load in the mice brain was evaluated by TCID50 titration method. RESULTS: Datura (ayurvedic preparation) was found to be nontoxic up to 2000 mg/kg in Swiss albino mice, i.e., 60 mg/30 g of mice, when administered (0.5 ml) orally and observed till 21 days. Up to 20% survival rate on the test group (PE of Datura extracts) up to 14 days postinfection as compared to the virus control group (10 LD(50)) was observed. No survival rate was observed in the postexposure group of Datura extract; however, the survival time was increased by 4 days as compared to the virus control group. Viral load of the infected mice brain sample was estimated in vero cell line, and 3 log reduction in the virus titer was observed in text group as compared to the virus control, suggesting that Datura extract has an in vivo antirabies activity. CONCLUSION: To the best of our knowledge, this is the first study of in vivo antiviral activity of an ayurvedic preparation of D. metel Linn. against rabies virus. Datura extracts have a potential in vivo antirabies activity. SUMMARY: In the present study, Datura metel Linn. (ayurvedic preparation) extract exhibited survival (20%) in the preexposure (PE) of the virus and the survival time was increased in the postexposure treatment where the disease was established. The mortality was observed, and the viral load was determined by titration method. [Image: see text] Abbreviation Used: TCID50: tissue culture infectious dose 50; LD50: lethal dose 50; RV CVS: Rabies virus challenge virus standard; PE: Pre exposure; IC: intracerebral; PI: post infection; FITC: Fluorescein isothiocyanate
format Online
Article
Text
id pubmed-5855366
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-58553662018-03-22 Assessment of In vivo Antiviral Potential of Datura metel Linn. Extracts against Rabies Virus Roy, Soumen Samant, Lalit Ganjhu, Rajeshkumar Mukherjee, Sandeepan Chowdhary, Abhay Pharmacognosy Res Original Article OBJECTIVE: The soxhlet, cold, and ayurvedic extracts of Datura metel Linn. were evaluated for in vivo antirabies activity. MATERIALS AND METHODS: Soxhlet and cold extraction method were used to extract Datura (fruit and seed) extracts, and ayurvedic extraction of Datura was prepared. In vivo toxicity assay was performed as per the OECD 420. LD(50) dose was calculated by Reed and Muench method. The in vivo antirabies activity was screened in Swiss albino mice with the virus challenge dose of 10 LD(50) (intracerebrally) in both preexposure (PE) and postexposure treatment with oral administration of Datura extracts in Swiss albino mice and observed for 21 days. The virus load in the mice brain was evaluated by TCID50 titration method. RESULTS: Datura (ayurvedic preparation) was found to be nontoxic up to 2000 mg/kg in Swiss albino mice, i.e., 60 mg/30 g of mice, when administered (0.5 ml) orally and observed till 21 days. Up to 20% survival rate on the test group (PE of Datura extracts) up to 14 days postinfection as compared to the virus control group (10 LD(50)) was observed. No survival rate was observed in the postexposure group of Datura extract; however, the survival time was increased by 4 days as compared to the virus control group. Viral load of the infected mice brain sample was estimated in vero cell line, and 3 log reduction in the virus titer was observed in text group as compared to the virus control, suggesting that Datura extract has an in vivo antirabies activity. CONCLUSION: To the best of our knowledge, this is the first study of in vivo antiviral activity of an ayurvedic preparation of D. metel Linn. against rabies virus. Datura extracts have a potential in vivo antirabies activity. SUMMARY: In the present study, Datura metel Linn. (ayurvedic preparation) extract exhibited survival (20%) in the preexposure (PE) of the virus and the survival time was increased in the postexposure treatment where the disease was established. The mortality was observed, and the viral load was determined by titration method. [Image: see text] Abbreviation Used: TCID50: tissue culture infectious dose 50; LD50: lethal dose 50; RV CVS: Rabies virus challenge virus standard; PE: Pre exposure; IC: intracerebral; PI: post infection; FITC: Fluorescein isothiocyanate Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC5855366/ /pubmed/29568197 http://dx.doi.org/10.4103/pr.pr_121_17 Text en Copyright: © 2018 Pharmacognosy Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Roy, Soumen
Samant, Lalit
Ganjhu, Rajeshkumar
Mukherjee, Sandeepan
Chowdhary, Abhay
Assessment of In vivo Antiviral Potential of Datura metel Linn. Extracts against Rabies Virus
title Assessment of In vivo Antiviral Potential of Datura metel Linn. Extracts against Rabies Virus
title_full Assessment of In vivo Antiviral Potential of Datura metel Linn. Extracts against Rabies Virus
title_fullStr Assessment of In vivo Antiviral Potential of Datura metel Linn. Extracts against Rabies Virus
title_full_unstemmed Assessment of In vivo Antiviral Potential of Datura metel Linn. Extracts against Rabies Virus
title_short Assessment of In vivo Antiviral Potential of Datura metel Linn. Extracts against Rabies Virus
title_sort assessment of in vivo antiviral potential of datura metel linn. extracts against rabies virus
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855366/
https://www.ncbi.nlm.nih.gov/pubmed/29568197
http://dx.doi.org/10.4103/pr.pr_121_17
work_keys_str_mv AT roysoumen assessmentofinvivoantiviralpotentialofdaturametellinnextractsagainstrabiesvirus
AT samantlalit assessmentofinvivoantiviralpotentialofdaturametellinnextractsagainstrabiesvirus
AT ganjhurajeshkumar assessmentofinvivoantiviralpotentialofdaturametellinnextractsagainstrabiesvirus
AT mukherjeesandeepan assessmentofinvivoantiviralpotentialofdaturametellinnextractsagainstrabiesvirus
AT chowdharyabhay assessmentofinvivoantiviralpotentialofdaturametellinnextractsagainstrabiesvirus